BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vega P, Valentín F, Cubiella J. Colorectal cancer diagnosis: Pitfalls and opportunities. World J Gastrointest Oncol 2015; 7(12): 422-433 [PMID: 26690833 DOI: 10.4251/wjgo.v7.i12.422] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 38] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Alonso-Molero J, González-Donquiles C, Fernández-Villa T, de Souza-Teixeira F, Vilorio-Marqués L, Molina AJ, Martín V. Alterations in PGC1α expression levels are involved in colorectal cancer risk: a qualitative systematic review. BMC Cancer 2017;17:731. [PMID: 29121859 DOI: 10.1186/s12885-017-3725-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
2 Fraser CG. Faecal immunochemical tests (FIT) in the assessment of patients presenting with lower bowel symptoms: Concepts and challenges. Surgeon. 2018;16:302-308. [PMID: 29548552 DOI: 10.1016/j.surge.2018.01.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
3 Huang Y, Liu N, Liu J, Liu Y, Zhang C, Long S, Luo G, Zhang L, Zhang Y. Mutant p53 drives cancer chemotherapy resistance due to loss of function on activating transcription of PUMA. Cell Cycle 2019;18:3442-55. [PMID: 31726940 DOI: 10.1080/15384101.2019.1688951] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
4 Du Z, Tang CH, Li LJ, Kang L, Zhao J, Jin L, Wang CQ, Su CM. Angiopoietin-2 gene polymorphisms are biomarkers for the development and progression of colorectal cancer in Han Chinese. Int J Med Sci 2020;17:97-102. [PMID: 31929743 DOI: 10.7150/ijms.37675] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Steele RJC, Fraser CG. Faecal Immunochemical Tests (FIT) for Haemoglobin for Timely Assessment of Patients with Symptoms of Colorectal Disease. In: Olsson L, editor. Timely Diagnosis of Colorectal Cancer. Cham: Springer International Publishing; 2018. pp. 39-66. [DOI: 10.1007/978-3-319-65286-3_3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Ewing M, Naredi P, Zhang C, Månsson J. Diagnostic profile characteristics of cancer patients with frequent consultations in primary care before diagnosis: a case-control study. Fam Pract 2018;35:559-66. [PMID: 29546418 DOI: 10.1093/fampra/cmy012] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Abdolahi HM, Asiabar AS, Azami-Aghdash S, Pournaghi-Azar F, Rezapour A. Cost-effectiveness of Colorectal Cancer Screening and Treatment Methods: Mapping of Systematic Reviews. Asia Pac J Oncol Nurs 2018;5:57-67. [PMID: 29379836 DOI: 10.4103/apjon.apjon_50_17] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Sadeghi H, Nazemalhosseini-Mojarad E, Sahebi U, Fazeli E, Azizi-Tabesh G, Yassaee VR, Savabkar S, Asadzadeh Aghdaei H, Zali MR, Mirfakhraie R. Novel long noncoding RNAs upregulation may have synergistic effects on the CYP24A1 and PFDN4 biomarker role in human colorectal cancer. J Cell Physiol 2021;236:2051-7. [PMID: 32743796 DOI: 10.1002/jcp.29992] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Bailey JA, Ibrahim H, Bunce J, Chapman CJ, Morling JR, Simpson JA, Humes DJ, Banerjea A. Quantitative FIT stratification is superior to NICE referral criteria NG12 in a high-risk colorectal cancer population. Tech Coloproctol 2021. [PMID: 34263362 DOI: 10.1007/s10151-021-02466-z] [Reference Citation Analysis]
10 Wang H, He C, Yang Z, Gao S, Li L, Sun X, Fang L, Liu N, Li H. Proteomics analysis of up-regulated NPM1 protein in colorectal cancer. Chem Res Chin Univ 2016;32:402-5. [DOI: 10.1007/s40242-016-5519-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
11 Mowat C, Digby J, Strachan JA, McCann RK, Carey FA, Fraser CG, Steele RJ. Faecal haemoglobin concentration thresholds for reassurance and urgent investigation for colorectal cancer based on a faecal immunochemical test in symptomatic patients in primary care. Ann Clin Biochem 2021;58:211-9. [PMID: 33334134 DOI: 10.1177/0004563220985547] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Digby J, Cleary S, Gray L, Datt P, Goudie DR, Steele RJC, Strachan JA, Humphries A, Fraser CG, Mowat C. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.United European Gastroenterol J. 2020;8:559-566. [PMID: 32213041 DOI: 10.1177/2050640620913674] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Quyn AJ, Steele RJ, Digby J, Strachan JA, Mowat C, McDonald PJ, Carey FA, Godber IM, Younes HB, Fraser CG. Application of NICE guideline NG12 to the initial assessment of patients with lower gastrointestinal symptoms: Not FIT for purpose? Ann Clin Biochem. 2018;55:69-76. [PMID: 28661203 DOI: 10.1177/0004563217707981] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
14 Schurink NW, Lambregts DMJ, Beets-Tan RGH. Diffusion-weighted imaging in rectal cancer: current applications and future perspectives. Br J Radiol 2019;92:20180655. [PMID: 30433814 DOI: 10.1259/bjr.20180655] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 18.0] [Reference Citation Analysis]
15 Virdee PS, Kirtley S, Elhussein L, Watkinson PJ, Holt TA, Birks J. Components of the full blood count as risk factors for colorectal cancer detection: a systematic review protocol. BMJ Open 2019;9:e032759. [PMID: 31848170 DOI: 10.1136/bmjopen-2019-032759] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Mozdiak E, Weldeselassie Y, Mcfarlane M, Tabuso M, Widlak MM, Dunlop A, Tsertsvadze A, Arasaradnam RP. Systematic review with meta-analysis of over 90 000 patients. Does fast-track review diagnose colorectal cancer earlier? Aliment Pharmacol Ther 2019;50:348-72. [DOI: 10.1111/apt.15378] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
17 Lee SHF, Abdul Rahman H, Abidin N, Ong SK, Leong E, Naing L. Survival of colorectal cancer patients in Brunei Darussalam: comparison between 2002-09 and 2010-17. BMC Cancer 2021;21:477. [PMID: 33926405 DOI: 10.1186/s12885-021-08224-6] [Reference Citation Analysis]
18 Westwood M, Lang S, Armstrong N, van Turenhout S, Cubiella J, Stirk L, Ramos IC, Luyendijk M, Zaim R, Kleijnen J, Fraser CG. Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance. BMC Med. 2017;15:189. [PMID: 29061126 DOI: 10.1186/s12916-017-0944-z] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 14.8] [Reference Citation Analysis]
19 Liang H, Yang L, Tao L, Shi L, Yang W, Bai J, Zheng D, Wang N, Ji J. Data mining-based model and risk prediction of colorectal cancer by using secondary health data: A systematic review. Chin J Cancer Res 2020;32:242-51. [PMID: 32410801 DOI: 10.21147/j.issn.1000-9604.2020.02.11] [Reference Citation Analysis]
20 Ma J, Wang P, Huang L, Qiao J, Li J. Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal cancer. BMC Med Genomics 2021;14:60. [PMID: 33639954 DOI: 10.1186/s12920-021-00905-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Han Y, Qu YQ, Mok SWF, Chen J, Xia CL, He HQ, Li Z, Zhang W, Qiu CL, Liu L, Law BYK, Wong VKW. A Novel Drug Resistance Mechanism: Genetic Loss of Xeroderma Pigmentosum Complementation Group C (XPC) Enhances Glycolysis-Mediated Drug Resistance in DLD-1 Colon Cancer Cells. Front Pharmacol 2019;10:912. [PMID: 31551763 DOI: 10.3389/fphar.2019.00912] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Blackmore T, Chepulis L, Keenan R, Kidd J, Stokes T, Weller D, Emery J, Lawrenson R. How do colorectal cancer patients rate their GP: a mixed methods study. BMC Fam Pract 2021;22:67. [PMID: 33832431 DOI: 10.1186/s12875-021-01427-7] [Reference Citation Analysis]
23 Zhang L, Zhang Y, Tang CH, Su CM. RAD52 gene polymorphisms are associated with risk of colorectal cancer in a Chinese Han population. Medicine (Baltimore) 2017;96:e8994. [PMID: 29245274 DOI: 10.1097/MD.0000000000008994] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
24 Tolstrup J, Madsen RC, Sneftrup MV, Niclasen B. Greenlandic patients with colorectal cancer: symptomatology, primary investigations and differences in diagnostic intervals between Nuuk and the rest of the country. Int J Circumpolar Health 2017;76:1344086. [PMID: 28705121 DOI: 10.1080/22423982.2017.1344086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
25 Gallardo-Gómez M, De Chiara L, Álvarez-Chaver P, Cubiella J. Colorectal cancer screening and diagnosis: omics-based technologies for development of a non-invasive blood-based method. Expert Rev Anticancer Ther 2021;21:723-38. [PMID: 33507120 DOI: 10.1080/14737140.2021.1882858] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Kunigenas L, Stankevicius V, Dulskas A, Budginaite E, Alzbutas G, Stratilatovas E, Cordes N, Suziedelis K. 3D Cell Culture-Based Global miRNA Expression Analysis Reveals miR-142-5p as a Theranostic Biomarker of Rectal Cancer Following Neoadjuvant Long-Course Treatment. Biomolecules 2020;10:E613. [PMID: 32316138 DOI: 10.3390/biom10040613] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
27 Obuch JC, Ahnen DJ. Colorectal Cancer: Genetics is Changing Everything. Gastroenterol Clin North Am. 2016;45:459-476. [PMID: 27546843 DOI: 10.1016/j.gtc.2016.04.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
28 Fraser CG. Faecal immunochemical tests for haemoglobin (FIT) in the assessment of patients with lower abdominal symptoms: current controversies. Gastroenterol Hepatol 2019;42:263-70. [PMID: 30459060 DOI: 10.1016/j.gastrohep.2018.09.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
29 Benton SC, Fraser CG. Faecal immunochemical tests in the COVID-19 pandemic; safety-netting of patients with symptoms and low faecal haemoglobin concentration - can a repeat test be used? Ann Clin Biochem 2021;58:163-5. [PMID: 33016079 DOI: 10.1177/0004563220967569] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Mello MRSP, Moura SF, Muzi CD, GuimarÃes RM. CLINICAL EVALUATION AND PATTERN OF SYMPTOMS IN COLORECTAL CANCER PATIENTS. Arq Gastroenterol 2020;57:131-6. [PMID: 32401950 DOI: 10.1590/s0004-2803.202000000-24] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Iovanescu D, Frandes M, Lungeanu D, Burlea A, Miutescu BP, Miutescu E. Diagnosis reliability of combined flexible sigmoidoscopy and fecal-immunochemical test in colorectal neoplasia screening. Onco Targets Ther 2016;9:6819-28. [PMID: 27853376 DOI: 10.2147/OTT.S122425] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
32 Westwood M, Corro Ramos I, Lang S, Luyendijk M, Zaim R, Stirk L, Al M, Armstrong N, Kleijnen J. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis. Health Technol Assess 2017;21:1-234. [PMID: 28643629 DOI: 10.3310/hta21330] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 11.3] [Reference Citation Analysis]
33 Digby J, Steele RJ, Strachan JA, Mowat C, Anderson AS, Mccann R, Law L, Fraser CG. Do other variables add value to assessment of the risk of colorectal disease using faecal immunochemical tests for haemoglobin? Ann Clin Biochem 2019;56:472-9. [DOI: 10.1177/0004563219839423] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
34 McSorley ST, Digby J, Clyde D, Cruickshank N, Burton P, Barker L, Strachan JA, Fraser CG, Smith K, Mowat C, Winter J, Steele RJC. Yield of colorectal cancer at colonoscopy according to faecal haemoglobin concentration in symptomatic patients referred from primary care. Colorectal Dis 2021;23:1615-21. [PMID: 33064898 DOI: 10.1111/codi.15405] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
35 Digby J, Strachan JA, Mowat C, Steele RJC, Fraser CG. Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational study. BMC Gastroenterol 2019;19:213. [PMID: 31829141 DOI: 10.1186/s12876-019-1135-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
36 Simelane NWN, Kruger CA, Abrahamse H. Targeted Nanoparticle Photodynamic Diagnosis and Therapy of Colorectal Cancer. Int J Mol Sci 2021;22:9779. [PMID: 34575942 DOI: 10.3390/ijms22189779] [Reference Citation Analysis]
37 Alatise OI, Fischer SE, Ayandipo OO, Omisore AG, Olatoke SA, Kingham TP. Health-Seeking Behavior and Barriers to Care in Patients With Rectal Bleeding in Nigeria. J Glob Oncol 2017;3:749-56. [PMID: 29244996 DOI: 10.1200/JGO.2016.006601] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
38 Yang YC, Wang D, Jin L, Yao HW, Zhang JH, Wang J, Zhao XM, Shen CY, Chen W, Wang XL, Shi R, Chen SY, Zhang ZT. Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients. Biosci Rep 2018;38:BSR20180322. [PMID: 29914973 DOI: 10.1042/BSR20180322] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 8.7] [Reference Citation Analysis]